QL
CRVS icon

Quarry LP’s Corvus Pharmaceuticals CRVS Stock Holding History

Quarry LP’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$627 Buy
+42
New +$583 ﹤0.01% 2113
2025
Q4 		– Sell
-3,653
Closed -$26.9K – 2227
2025
Q3 		$26.9K Buy
+3,653
New +$18.7K 0.01% 1221

Other funds holding CRVS

OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ASP
Adams Street Partners Chicago, Illinois $443M AUM 49.46% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Quarry LP's CRVS Position: Q2 2026 in Review

Quarry LP opened a new position in Corvus Pharmaceuticals (CRVS) in Q2 2026: 42 shares worth $627. The stake represents ﹤0.01% of the portfolio and ranks #2113 among its holdings. This is a return to the name: Quarry LP previously reported a position in CRVS as recently as Q3 2025.

Quarry LP first reported a position in CRVS in Q3 2025 and has held it in 2 quarters since. The position peaked at $26.9K in Q3 2025. 173 funds tracked by Wall St. Rank hold CRVS as of Q2 2026.

  • Quarry LP held 42 shares of Corvus Pharmaceuticals worth $627 as of Q2 2026.
  • Corvus Pharmaceuticals was a new Quarry LP position in Q2 2026.
  • Corvus Pharmaceuticals made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #2113 holding.
  • Quarry LP first reported a position in Corvus Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • Quarry LP's Corvus Pharmaceuticals position peaked at $26.9K in Q3 2025.
  • 173 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.